Kite, a Gilead company, says the US Food and Drug Administration (FDA) has approved commercial production at the company's new CAR T-cell therapy manufacturing facility in Frederick, Maryland.
Image: https://www.biopharma-reporter.com
SUBSCRIBE
Biohealth Innovation
Founding Member of
